Home › Sickle Cell Disease › District of Columbia
Sickle Cell Disease clinical trials in District of Columbia
10 studies for Sickle Cell Disease are looking for participants at sites in District of Columbia.
Cities in District of Columbia
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- Childrens National Hospital, Washington D.C.
RecruitingPhase 3
Ages 12 to 100 · All sexes · Updated Sep 28, 2026 · NCT06439082A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- Childrens National Medical Ctr, Washington D.C.
- MedStar Hlth Res Institute, Washington D.C.
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 17, 2026 · NCT06612268ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Georgetown University, Washington D.C.
- Children's National Hemophilia Center, Washington D.C.
RecruitingObservational study
All ages · All sexes · Updated Aug 17, 2026 · NCT04398628Cooperative Assessment of Late Effects for SCD Curative Therapies
- Children's National Medical Center, Washington D.C.
RecruitingObservational study
Ages 4 to 65 · All sexes · Updated Jul 27, 2026 · NCT05153967Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
- Children's National Hospital (MRD-HCT), Washington D.C.
RecruitingObservational study
Ages 3 to 20 · All sexes · Updated Jun 4, 2026 · NCT06941389Intravenous L-Citrulline for Vaso-occlusive Pain Episode in Sickle Cell Disease
- Children's National Hospital, Washington D.C.
RecruitingPhase 2
Ages 4 to 21 · All sexes · Updated Apr 13, 2026 · NCT06635902Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease
- Children's National Health System, Washington D.C.
RecruitingPhase 2
Ages 2 to 25 · All sexes · Updated Mar 10, 2026 · NCT03587272Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody
- Children's National Hospital, Washington D.C.
RecruitingPhase 2
Ages 2 to 25 · All sexes · Updated Sep 26, 2025 · NCT06358638Advancing Feasibility and Acceptability of Digital Cognitive Rehabilitation in Sickle Cell Disease
- Children's National Hospital, Washington D.C.
Recruiting
Ages 7 to 16 · All sexes · Updated Feb 13, 2025 · NCT06770010Feasibility and Efficacy of Attentional-Control Training in Sickle Cell Disease
- Children's National Hospital, Washington D.C.
Recruiting
Ages 8 to 16 · All sexes · Updated Jan 10, 2025 · NCT05099874From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.